Paris System for Reporting Urinary Cytology

Eva M. Wojcik, M.D.Chair of Pathology and Laboratory MedicineHelen M. and Raymond M. Galvin Professor of Pathology & UrologyRegional Laboratory Medical Director, Loyola MedicineLoyola University Medical Center Department of Pathology and Laboratory MedicineMaywood IL, USADaniel F. I. Kurtycz MDEmeritus Professor, Department of Pathology and Laboratory MedicineUniversity of Wisconsin School of Medicine and Public HealthEmeritus Medical Director,Wisconsin State Laboratory of HygieneMadison, Wisconsin, USA,Dorothy L. Rosenthal, MDProfessor Emerita of Pathology/CytopathologyThe Johns Hopkins School of MedicineBaltimore MD, USA

• Pathogenesis of Urothelial Carcinoma.- Adequacy of Urine Specimens (Adequacy).- Negative for High-Grade Urothelial Carcinoma (Negative).- Atypical Urothelial Cells (AUC).- Suspicious for High-Grade Urothelial Carcinoma (Suspicious).- High-Grade Urothelial Carcinoma (HGUC).- Low-Grade Urothelial Neoplasia (LGUN).- Cytology of the Upper Urinary Tract.- Other Malignancies Primary and Metastatic and Miscellaneous Lesions.- Ancillary Studies in Urinary Cytology.- Cytopreparatory Techniques.- Risk of Malignancy (ROM) and Clinical Management.